1.515 USD
-0.07 (-4.11%)
Overall SLSN gets a fundamental rating of 2 out of 10. We evaluated SLSN against 83 industry peers in the Chemicals industry. SLSN has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, SLSN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
SLSN had positive earnings in the past year.
In the past year SLSN has reported a negative cash flow from operations.
In multiple years SLSN reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: SLSN reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.98%, SLSN is in the better half of the industry, outperforming 63.86% of the companies in the same industry.
The Return On Equity of SLSN (6.21%) is better than 68.67% of its industry peers.
SLSN has a worse Return On Invested Capital (2.22%) than 66.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.98% | ||
| ROE | 6.21% | ||
| ROIC | 2.22% |
ROA(3y)-4.23%
ROA(5y)0.56%
ROE(3y)-82.95%
ROE(5y)-36.3%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of SLSN (1.72%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SLSN has remained more or less at the same level.
SLSN's Operating Margin of 1.87% is on the low side compared to the rest of the industry. SLSN is outperformed by 72.29% of its industry peers.
In the last couple of years the Operating Margin of SLSN has grown nicely.
With a Gross Margin value of 24.77%, SLSN perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
In the last couple of years the Gross Margin of SLSN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.87% | ||
| PM (TTM) | 1.72% | ||
| GM | 24.77% |
OM growth 3Y4.13%
OM growth 5YN/A
PM growth 3Y0.93%
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y8.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SLSN is destroying value.
SLSN has more shares outstanding than it did 1 year ago.
SLSN has more shares outstanding than it did 5 years ago.
SLSN has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.81, we must say that SLSN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of SLSN (0.81) is worse than 75.90% of its industry peers.
SLSN has a Debt/Equity ratio of 0.92. This is a neutral value indicating SLSN is somewhat dependend on debt financing.
SLSN has a worse Debt to Equity ratio (0.92) than 62.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.81 |
ROIC/WACC0.15
WACC15.17%
2.3 Liquidity
A Current Ratio of 1.84 indicates that SLSN should not have too much problems paying its short term obligations.
The Current ratio of SLSN (1.84) is comparable to the rest of the industry.
A Quick Ratio of 0.78 indicates that SLSN may have some problems paying its short term obligations.
SLSN has a worse Quick ratio (0.78) than 81.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
The earnings per share for SLSN have decreased strongly by -50.00% in the last year.
SLSN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.20% yearly.
Looking at the last year, SLSN shows a very strong growth in Revenue. The Revenue has grown by 30.04%.
SLSN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.15% yearly.
EPS 1Y (TTM)-50%
EPS 3Y9.2%
EPS 5YN/A
EPS Q2Q%-150%
Revenue 1Y (TTM)30.04%
Revenue growth 3Y21.09%
Revenue growth 5Y33.15%
Sales Q2Q%-13.46%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 151.50, which means the current valuation is very expensive for SLSN.
Compared to the rest of the industry, the Price/Earnings ratio of SLSN indicates a slightly more expensive valuation: SLSN is more expensive than 66.27% of the companies listed in the same industry.
SLSN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SLSN indicates a rather expensive valuation: SLSN more expensive than 84.34% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 58.82 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
SLSN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:SLSN (1/6/2026, 12:40:22 PM)
1.515
-0.07 (-4.11%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners5.71%
Inst Owner ChangeN/A
Ins Owners26.62%
Ins Owner Change0.11%
Market Cap106.87M
Revenue(TTM)62.15M
Net Income(TTM)1.07M
AnalystsN/A
Price TargetN/A
Short Float %3.99%
Short Ratio18.99
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.5 | ||
| Fwd PE | N/A | ||
| P/S | 1.72 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 6.2 | ||
| P/tB | 6.2 | ||
| EV/EBITDA | 58.82 |
EPS(TTM)0.01
EY0.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.88
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.98% | ||
| ROE | 6.21% | ||
| ROCE | 3.22% | ||
| ROIC | 2.22% | ||
| ROICexc | 2.24% | ||
| ROICexgc | 2.24% | ||
| OM | 1.87% | ||
| PM (TTM) | 1.72% | ||
| GM | 24.77% | ||
| FCFM | N/A |
ROA(3y)-4.23%
ROA(5y)0.56%
ROE(3y)-82.95%
ROE(5y)-36.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y17.57%
ROICexgc growth 5YN/A
ROICexc growth 3Y17.57%
ROICexc growth 5YN/A
OM growth 3Y4.13%
OM growth 5YN/A
PM growth 3Y0.93%
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y8.11%
F-Score3
Asset Turnover1.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.66 | ||
| Cap/Depr | 474.12% | ||
| Cap/Sales | 6.9% | ||
| Interest Coverage | 1.43 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.84 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 0.81 |
F-Score3
WACC15.17%
ROIC/WACC0.15
Cap/Depr(3y)375.85%
Cap/Depr(5y)357.51%
Cap/Sales(3y)6.36%
Cap/Sales(5y)6.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3Y9.2%
EPS 5YN/A
EPS Q2Q%-150%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.04%
Revenue growth 3Y21.09%
Revenue growth 5Y33.15%
Sales Q2Q%-13.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-66.41%
EBIT growth 3Y26.09%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2511.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-688.02%
OCF growth 3Y-5.29%
OCF growth 5YN/A
SOLESENCE INC / SLSN FAQ
What is the ChartMill fundamental rating of SOLESENCE INC (SLSN) stock?
ChartMill assigns a fundamental rating of 2 / 10 to SLSN.
Can you provide the valuation status for SOLESENCE INC?
ChartMill assigns a valuation rating of 0 / 10 to SOLESENCE INC (SLSN). This can be considered as Overvalued.
What is the profitability of SLSN stock?
SOLESENCE INC (SLSN) has a profitability rating of 4 / 10.